GlassScriptPhysician profile
John R Catania
NPI 1356092407
$7,757.21
in general payments reported to CMS, 2019-2025
29 companies · $2,347 in 2025
The $2,347 reported for 2025 was more than what 95% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,194 · 2023: $2,037 · 2024: $2,179 · 2025: $2,347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,546 · Education: $17.38.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,546.20 |
| Education | $17.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,852.96 | 2022-2025 | Fasenra, Airsupra, Breztri |
| Glaxosmithkline, LLC. | $1,575.66 | 2022-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Takeda Pharmaceuticals U.S.A., INC. | $1,034.10 | 2022-2025 | Glassia |
| Regeneron Healthcare Solutions, INC. | $582.47 | 2022-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $447.04 | 2022-2025 | Ofev, Jascayd, Spiriva Respimat |
| Grifols USA, LLC | $277.91 | 2022-2025 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $250.64 | 2024-2025 | Winrevair |
| Genzyme Corporation | $231.12 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $212.89 | 2022-2023 | |
| Stryker Corporation | $207.09 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Insmed, INC. | $178.53 | 2023-2025 | Arikayce, Brinsupri |
| Abiomed | $128.40 | 2025 | |
| United Therapeutics Corporation | $99.24 | 2022-2025 | Tyvaso, Tyvaso |
| Abbvie INC. | $73.96 | 2022-2024 | |
| Philips North America LLC | $71.56 | 2022-2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $60.43 | 2022-2024 | Nuzyra |
| Actelion Pharmaceuticals US, INC. | $51.65 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| Fisher & Paykel Healthcare INC | $51.29 | 2022 | |
| Baxter Healthcare | $46.49 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Verona Pharma, INC. | $46.28 | 2025 | Ohtuvayre |
| Amgen INC. | $44.22 | 2023 | Tezspire |
| Electromed, INC. | $44.16 | 2022-2023 | Smartvest |
| Mallinckrodt Hospital Products INC. | $36.27 | 2025 | Acthar |
| Ani Pharmaceuticals, INC. | $34.86 | 2025 | Purified Cortrophin Gel |
| Resmed Corp | $32.16 | 2022 | |
| Mylan Specialty L.P. | $27.67 | 2022-2024 | Yupelri |
| Viatris Specialty LLC | $24.09 | 2025 | Yupelri |
| Tactile Systems Technology INC | $20.81 | 2023 | Entre Plus, Flexitouch Plus |
| Intuitive Surgical, INC. | $13.26 | 2023 | Da Vinci Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Catania listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.